However, unlike that seen in the B-CLL cells, co-stimulation of the cAMP signaling pathway enhanced this down regulation, rather than preventing it, leading to a profound reduction in the expression of GR. This evidence concerns the gene NR3C1 and B-cell chronic lymphocytic leukemia.